Cargando…

The influence of TLR4 agonist lipopolysaccharides on hepatocellular carcinoma cells and the feasibility of its application in treating liver cancer

OBJECTIVE: This study was designed to explore the influence of Toll-like receptor 4 (TLR4) agonist lipopolysaccharides (LPS) on liver cancer cell and the feasibility to perform liver cancer adjuvant therapy. METHODS: Human liver cancer cell lines HepG2, H7402, and PLC/PRF/5 were taken as models, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Junsheng, Sun, Ranran, Shen, Shen, Yu, Zujiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551308/ https://www.ncbi.nlm.nih.gov/pubmed/26345468 http://dx.doi.org/10.2147/OTT.S86536

Ejemplares similares

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma
por: Zhou, Zhimei, et al.
Publicado: (2021)

The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy
por: Guizhen, Zhang, et al.
Publicado: (2022)

TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
por: Ho, Victor, et al.
Publicado: (2015)

TLR7 agonist induced repression of hepatocellular carcinoma via the TLR7-IKK-NF-κB-IL6 signaling pathway
por: REN, XINGBIN, et al.
Publicado: (2016)

Comparison of Gene Expression by Sheep and Human Blood Stimulated with the TLR4 Agonists Lipopolysaccharide and Monophosphoryl Lipid A
por: Enkhbaatar, Perenlei, et al.
Publicado: (2015)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma
por: Li, Shasha, et al.
Publicado: (2019)

The Nod2 Agonist Muramyl Dipeptide Cooperates with the TLR4 Agonist Lipopolysaccharide to Enhance IgG2b Production in Mouse B Cells
por: Lee, Sang-Hoon, et al.
Publicado: (2019)

Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
por: Cascini, Caterina, et al.
Publicado: (2023)

Expression and clinical significance of miR-3615 in hepatocellular carcinoma
por: Yuan, Xin, et al.
Publicado: (2021)

Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma
por: Zhang, Yingying, et al.
Publicado: (2020)

miR-450b-5p loss mediated KIF26B activation promoted hepatocellular carcinoma progression by activating PI3K/AKT pathway
por: Li, Hua, et al.
Publicado: (2019)

TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism
por: Noack, J, et al.
Publicado: (2012)

Analysis of Multi-Layer RNA Modification Patterns for the Characterization of Tumor Immune Microenvironment in Hepatocellular Carcinoma
por: Xing, Jiyuan, et al.
Publicado: (2021)

Norcantharidin down-regulates iron contents in the liver and spleen of lipopolysaccharide-treated mice
por: Zheng, Jie, et al.
Publicado: (2022)

Recognition of lipopolysaccharide pattern by TLR4 complexes
por: Park, Beom Seok, et al.
Publicado: (2013)

TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis
por: Yuan, Ming-Ming, et al.
Publicado: (2015)

Deoxyguanosine is a TLR7 agonist
por: Davenne, Tamara, et al.
Publicado: (2019)

TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma
por: Zhou, Shuang, et al.
Publicado: (2019)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
por: Sun, Jinghua, et al.
Publicado: (2012)

Lipopolysaccharide mediates immuno-pathological alterations in young chicken liver through TLR4 signaling
por: Huang, Xi-Yao, et al.
Publicado: (2017)

The clinical significance of lipopolysaccharide binding protein in hepatocellular carcinoma
por: Cai, Quan-Yu, et al.
Publicado: (2020)

miR-935 Promotes Liver Cancer Cell Proliferation and Migration by Targeting SOX7
por: Liu, Xiaorui, et al.
Publicado: (2017)

Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma
por: Shen, Wanying, et al.
Publicado: (2022)

TLR2 and TLR9 modulate enteric nervous system inflammatory responses to lipopolysaccharide
por: Burgueño, Joan F., et al.
Publicado: (2016)

Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis
por: Wang, Ruifang, et al.
Publicado: (2021)

Comparison of human B cell activation by TLR7 and TLR9 agonists
por: Hanten, John A, et al.
Publicado: (2008)

Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists
por: Cheng, Kui, et al.
Publicado: (2015)

Trial Watch: experimental TLR7/TLR8 agonists for oncological indications
por: Frega, Giorgio, et al.
Publicado: (2020)

Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma
por: Pan, Caixu, et al.
Publicado: (2022)

An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning
por: Guizhen, Zhang, et al.
Publicado: (2023)

The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma
por: Shen, Jiliang, et al.
Publicado: (2017)

Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non‐alcoholic steatohepatitis model
por: Shimizu, Yoshio, et al.
Publicado: (2020)

Integrated Bioinformatic Analysis Identifies TIPIN as a Prognostic Biomarker in Hepatocellular Carcinoma
por: Chen, Hui, et al.
Publicado: (2022)

Estrogen-Related Receptor γ Agonist DY131 Ameliorates Lipopolysaccharide-Induced Acute Liver Injury
por: Ma, Haoyang, et al.
Publicado: (2021)

Transcriptome-Wide 5-Methylcytosine Functional Profiling of Long Non-Coding RNA in Hepatocellular Carcinoma
por: He, Yuting, et al.
Publicado: (2020)

Gene signatures and prognostic values of m1A-related regulatory genes in hepatocellular carcinoma
por: Shi, Qingmiao, et al.
Publicado: (2020)

Microbial TLR Agonists and Humoral Immunopathogenesis in HIV Disease
por: Yu, Xiaocong, et al.
Publicado: (2013)

Trial watch: TLR3 agonists in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2020)

OMV Vaccines and the Role of TLR Agonists in Immune Response
por: Mancini, Francesca, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ldhjr06m9lojqiatshucndh2i4